Author's Profile

Marina Temkin

Financial Writer

Marina Temkin covered the venture capital ecosystem from 2021 to 2024, based in San Francisco. Previously with Venture Capital Journal, Marina wrote about the VC industry, and she was a reporter with Mergermarket in New York and San Francisco. She also has been a financial analyst and is a CFA charterholder. Marina received an economics degree from the University of California, Davis, and she attended the CUNY Graduate School of Journalism.

m-temkin-low-res-round.png

Articles by Marina Temkin

Why SignalFire doesn’t regret taking longer to raise $900M capital pool

SignalFire, which was the first VC to use a proprietary AI model to make investment decisions and help portfolio companies scale, has raised over $900 million for a set of new funds—nearly double the $500 million it closed in 2019.
February 14, 2023

Investor appetite, microfunds help seed investing defy startup drubbing

The buoyancy was supported in part by multi-stage VCs who pulled back from later stages and increased their participation in seed deals.
February 9, 2023

Slump puts startups’ fates in hands of all-powerful VC insiders

Judgment day is still coming for startups, and in many cases, companies’ existing investors will play the role of God in deciding their fate.
February 2, 2023

Why VC valuations look too high to limited partners

The valuations VC firms have been providing their LPs show that private market prices are still far from catching up to the steep drops of their public counterparts.
January 30, 2023

Arch Ventures-incubated clinical trials startup leaves stealth with $203M

Paradigm, a healthtech startup that has received a $203 million Series A, is creating technology to match patient records with clinical trial criteria.
January 26, 2023

Even startups with lots of runway probably can’t grow into those sky-high valuations

Valuation multiples may have fallen too far from their 2021 peaks for many late-stage companies to catch up, according to Pitchbook calculations using IVP data.
January 23, 2023

B Capital raises $2.1B growth fund as late-stage prices slowly fall

Multistage-focused firm B Capital Group has closed on its largest fund. The $2.1 billion venture growth vehicle comes even as backing for late-stage companies seems to be dropping.
January 18, 2023

Tech slump is testing even healthcare, the most resilient of sectors

No matter how resilient healthcare businesses may be to the economy’s cycles, they’re still subject to market valuations.
January 12, 2023

Startup life expectancy expected to fall

Company failure rate was extremely low during the last boom cycle. Investors expect that to change this year.
January 10, 2023

CVS has invested $100M in Carbon Health. Is yet more primary care M&A in the offing?

CVS failed to buy One Medical before Amazon scooped it up. Now, the drugstore giant is forging a partnership with Carbon Health, which also offers tech-enabled primary health services.
January 8, 2023